MedWatch

GN Hearing's CEO regards new OTC regulation positively

The framework for the future over-the-counter sales channel in the US extends beyond what CEO Gitte Aabo had anticipated. Overall, she is pleasantly surprised.

Photo: GN Store Nord / PR

The framework of the upcoming US sales channel for over-the-counter (OTC) hearing aids was recently made public, and the big hearing aid manufacturers have been reading the over 100-page document from the US Food and Drug Administration carefully.

So far, CEO at GN Hearing Gitte Aabo's opinion is positive, she explains.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs